Torvald Granfors
Overview
Explore the profile of Torvald Granfors including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
788
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al-Ubaidi F, Schultz N, Loseva O, Egevad L, Granfors T, Helleday T
Clin Cancer Res
. 2021 Nov;
27(21):6066.
PMID: 34725125
No abstract available.
2.
Hammarsten P, Josefsson A, Thysell E, Lundholm M, Hagglof C, Iglesias-Gato D, et al.
Mod Pathol
. 2019 Apr;
32(9):1310-1319.
PMID: 30980038
Based on gene-expression profiles, prostate tumors can be subdivided into subtypes with different aggressiveness and response to treatment. We investigated if similar clinically relevant subgroups can be identified simply by...
3.
Hammarsten P, Dahl Scherdin T, Hagglof C, Andersson P, Wikstrom P, Stattin P, et al.
PLoS One
. 2016 Oct;
11(10):e0164016.
PMID: 27764093
In the present study we have investigated whether Caveolin-1 expression in non-malignant and malignant prostate tissue is a potential prognostic marker for outcome in prostate cancer patients managed by watchful...
4.
Tarish F, Schultz N, Tanoglidi A, Hamberg H, Letocha H, Karaszi K, et al.
Sci Transl Med
. 2015 Nov;
7(312):312re11.
PMID: 26537259
Chemical castration improves responses to radiotherapy in prostate cancer, but the mechanism is unknown. We hypothesized that this radiosensitization is caused by castration-mediated down-regulation of nonhomologous end joining (NHEJ) repair...
5.
Nilsson M, Hagglof C, Hammarsten P, Thysell E, Stattin P, Egevad L, et al.
PLoS One
. 2015 Oct;
10(10):e0140985.
PMID: 26501565
Lysyl oxidase (LOX) has been shown to both promote and suppress tumor progression, but its role in prostate cancer is largely unknown. LOX immunoreactivity was scored in prostate tumor epithelium,...
6.
Stattin P, Vickers A, Sjoberg D, Johansson R, Granfors T, Johansson M, et al.
Eur Urol
. 2015 Feb;
68(2):207-13.
PMID: 25682340
Background: A disadvantage of prostate-specific antigen (PSA) for the early detection of prostate cancer (PCa) is that many men must be screened, biopsied, and diagnosed to prevent one death. Objective:...
7.
Hammarsten P, Winther J, Rudolfsson S, Haggstrom J, Karalija A, Egevad L, et al.
PLoS One
. 2014 Sep;
9(9):e105063.
PMID: 25215939
Background: ErbB2 is a member of the epidermal growth factor family of tyrosine kinases that is centrally involved in the pathogenesis of prostate cancer and several studies have reported that...
8.
Tidehag V, Hammarsten P, Egevad L, Granfors T, Stattin P, Leanderson T, et al.
Eur J Cancer
. 2014 Apr;
50(10):1829-1835.
PMID: 24726733
Purpose: To elucidate if the density of inflammatory cells expressing S100A9 in malignant and surrounding non-malignant prostate tissues is a prognostic marker for outcome in prostate cancer patients. Experimental Design:...
9.
Hagglof C, Hammarsten P, Stromvall K, Egevad L, Josefsson A, Stattin P, et al.
PLoS One
. 2014 Feb;
9(2):e86824.
PMID: 24505269
The TMPRSS2-ERG gene fusion is found in approximately half of all prostate cancers. The functional and prognostic significance of TMPRSS2-ERG is, however, not fully understood. Based on a historical watchful...
10.
Al-Ubaidi F, Schultz N, Loseva O, Egevad L, Granfors T, Helleday T
Clin Cancer Res
. 2013 Jan;
19(6):1547-56.
PMID: 23349316
Purpose: Neoadjuvant castration improves response to radiotherapy of prostate cancer. Here, we determine whether castration therapy impairs nonhomologous end-joining (NHEJ) repair of DNA double-strand breaks (DSB) by downregulating Ku70 protein...